These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37346975)

  • 1. Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells.
    Liu H; Chen C; Liao S; Sohaii DK; Cruz CRY; Burdo TH; Cradick TJ; Mehta A; Barrero C; Florez M; Gordon J; Grauzam S; Dressman J; Amini S; Bollard CM; Kaminski R; Khalili K
    Mol Ther Nucleic Acids; 2023 Jun; 32():1010-1025. PubMed ID: 37346975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
    Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
    J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An RNA-Directed Gene Editing Strategy for Attenuating the Infectious Potential of Feline Immunodeficiency Virus-Infected Cells: A Proof of Concept.
    Murphy BG; Wolf T; Vogel H; Castillo D; Woolard K
    Viruses; 2020 May; 12(5):. PubMed ID: 32380756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
    Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
    EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice.
    Dash PK; Chen C; Kaminski R; Su H; Mancuso P; Sillman B; Zhang C; Liao S; Sravanam S; Liu H; Waight E; Guo L; Mathews S; Sariyer R; Mosley RL; Poluektova LY; Caocci M; Amini S; Gorantla S; Burdo TH; Edagwa B; Gendelman HE; Khalili K
    Proc Natl Acad Sci U S A; 2023 May; 120(19):e2217887120. PubMed ID: 37126704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.
    Zhu W; Lei R; Le Duff Y; Li J; Guo F; Wainberg MA; Liang C
    Retrovirology; 2015 Feb; 12():22. PubMed ID: 25808449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 cure strategies: why CRISPR?
    Atkins AJ; Allen AG; Dampier W; Haddad EK; Nonnemacher MR; Wigdahl B
    Expert Opin Biol Ther; 2021 Jun; 21(6):781-793. PubMed ID: 33331178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy.
    Herskovitz J; Hasan M; Patel M; Kevadiya BD; Gendelman HE
    Methods Mol Biol; 2022; 2407():429-445. PubMed ID: 34985679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.
    Dash PK; Kaminski R; Bella R; Su H; Mathews S; Ahooyi TM; Chen C; Mancuso P; Sariyer R; Ferrante P; Donadoni M; Robinson JA; Sillman B; Lin Z; Hilaire JR; Banoub M; Elango M; Gautam N; Mosley RL; Poluektova LY; McMillan J; Bade AN; Gorantla S; Sariyer IK; Burdo TH; Young WB; Amini S; Gordon J; Jacobson JM; Edagwa B; Khalili K; Gendelman HE
    Nat Commun; 2019 Jul; 10(1):2753. PubMed ID: 31266936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
    Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
    Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
    Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of infectious HIV DNA by CRISPR-Cas9.
    Das AT; Binda CS; Berkhout B
    Curr Opin Virol; 2019 Oct; 38():81-88. PubMed ID: 31450074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus.
    Panfil AR; London JA; Green PL; Yoder KE
    Front Microbiol; 2018; 9():3107. PubMed ID: 30619186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas attack of HIV-1 proviral DNA can cause unintended deletion of surrounding cellular DNA.
    Liu Y; Binda CS; Berkhout B; Das AT
    J Virol; 2023 Dec; 97(12):e0133423. PubMed ID: 37982648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages.
    Hany L; Turmel MO; Barat C; Ouellet M; Tremblay MJ
    J Virol; 2022 Feb; 96(4):e0195321. PubMed ID: 34878918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line.
    Liu Y; Jeeninga RE; Klaver B; Berkhout B; Das AT
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9: a tool to eradicate HIV-1.
    Bhowmik R; Chaubey B
    AIDS Res Ther; 2022 Dec; 19(1):58. PubMed ID: 36457057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.
    Bialek JK; Dunay GA; Voges M; Schäfer C; Spohn M; Stucka R; Hauber J; Lange UC
    PLoS One; 2016; 11(6):e0158294. PubMed ID: 27341108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted CRISPR screen identifies ETS1 as a regulator of HIV latency.
    Ashokkumar M; Hafer TL; Felton A; Archin NM; Margolis DM; Emerman M; Browne EP
    bioRxiv; 2024 Aug; ():. PubMed ID: 39211204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.